文献速递技术与安全PET

AI方法在PET影像预测淋巴瘤预后中的表现:系统综述与荟萃分析

Performance of AI methods in PET-based imaging for outcome prediction in lymphoma: A systematic review and meta-analysis.
PubMed 文献 · Eur J Radiol · 2025-06-01

该系统综述与荟萃分析纳入75项原始研究,评估基于治疗前PET影像的人工智能方法预测淋巴瘤结局的性能。汇总分析显示AI对无进展生存期、总生存期和治疗反应均有较强预测能力,深度学习在PFS和治疗反应预测中表现更优。结论支持AI在精准医学中的潜在价值,但需前瞻性研究推动临床整合。

要点

  • 基于治疗前PET影像的AI模型对淋巴瘤PFS和OS具有较强预测性能。
  • 深度学习在PFS和治疗反应预测上优于其他AI方法。
  • 目前证据以回顾性研究为主,临床整合仍需前瞻性验证。

核心结论

  • AI方法尤其是深度学习,利用PET影像对淋巴瘤结局具有较强预测性能,支持其精准医学应用潜力。
  • 仍需进一步前瞻性研究以实现临床整合。

研究设计与样本

  • 共纳入75项原始研究,以非霍奇金淋巴瘤为主(n=61)。
  • AI方法包括深度学习(n=13)、机器学习(n=2)、机器学习/影像组学联合(n=23)和影像组学(n=37)。
  • 结局包括无进展生存期、总生存期或治疗反应,使用Stata进行荟萃分析、亚组分析、荟萃回归、敏感性分析和发表偏倚分析。

诊断标准与关键数值

  • PFS预测:汇总HR 4.11(3.20-5.29),AUC 0.78(0.68-0.86),C-index 0.79(0.76-0.83)。
  • OS预测:汇总HR 3.38(2.29-4.99),AUC 0.75(0.66-0.83),C-index 0.79(0.76-0.81)。
  • 治疗反应预测:汇总OR 5.36(1.53-18.78),AUC 0.85(0.74-0.92)。

临床应用与阅片要点

  • 治疗前PET影像的AI模型可用于淋巴瘤PFS、OS和治疗反应的预后分层参考。
  • 深度学习模型在PFS和治疗反应预测中表现更优,阅片时可关注相关AI辅助输出。

局限性

  • 纳入研究以回顾性为主,缺乏前瞻性验证。
  • 研究以非霍奇金淋巴瘤为主,其他淋巴瘤亚型证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the predictive performance of artificial intelligence (AI) methods using pre-treatment PET-based imaging for outcome prediction in lymphoma through a systematic review and meta-analysis.

METHODS: PubMed-MEDLINE, Scopus, and Web of Science were searched for original studies on AI prediction models using PET-based imaging in lymphoma up to October 2024. Eligible studies reported outcomes including progression-free survival (PFS), overall survival (OS), or treatment response. Meta-analyses, subgroup analyses, meta-regressions, sensitivity analysis, and publication bias analysis were conducted using Stata software.

RESULTS: Seventy-five studies were included, predominantly focusing on non-Hodgkin lymphoma (NHL, n = 61). AI methods included deep learning (DL, n = 13), machine learning (ML, n = 2), combined ML/radiomics (n = 23), and radiomics (n = 37). Pooled analyses showed strong predictive performance for PFS (HR: 4.11 [3.20-5.29], AUC: 0.78 [0.68-0.86], C-index: 0.79 [0.76-0.83]) and OS (HR: 3.38 [2.29-4.99], AUC: 0.75 [0.66-0.83], C-index: 0.79 [0.76-0.81]) in the main groups with consistent results in the validation groups. For treatment response, pooled OR was 5.36 [1.53-18.78], and AUC was 0.85 [0.74-0.92]. DL outperformed other AI methods in PFS and treatment response prediction.

CONCLUSION: AI methods, particularly DL, show strong predictive performance for lymphoma outcomes using PET-based imaging, supporting their potential utility in precision medicine. Further prospective studies are needed for clinical integration.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Mehrabi Nejad MM, Ghanbari Boroujeni MR, Hayati A, et al. Performance of AI methods in PET-based imaging for outcome prediction in lymphoma: A systematic review and meta-analysis. Eur J Radiol. 2025. PMID: 40466216. doi:10.1016/j.ejrad.2025.112204

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。